The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Valeant Pharmaceuticals International  (VRX) Trade Now »     Rate VRX  -  Discuss VRX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
50.0%
Top:
0.0%
Rate VRX:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

VRX: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Valeant's Promising Epilepsy Drug Graphic_rating_buy VRX
78%
 +9.28%
in 57 days
(closed on 07/30/09)
Valeant has a promising epilepsy drug, retigabine, that is significantly undervalued by Wall Street. Healey sees the stock doubling to $40 to $50 a share in the next 12 to 18 months - Joseph Healey, HEALTHCOR
By  jgarner3999   (+12.48%  risk: conservative)  06/03/09 Comment




From the Blogosphere

Save money, give stock to charity! Graphic_rating_sell VRX
-40.93%
in 145 days

Filed under: Palm Inc (PALM), Teva Pharm Indus ADR (TEVA), Stocks to Sell

Surviving this recession is foremost on peoples' minds, but giving to charity is especially important in times like these. So how can you effectively give while preserving your net worth?

If you plan on liquidating any profitable, or taxable, positions in the stock market thanks to the current uptrend and also want to give to your favorite charity, the strategy outlined below is key to optimizing your gift, as well as your capital.

<>Though giving cash to causes is the most popular form of charity, desperate times call f...
By  Daleela Farina   (+3.05%  risk: conservative)  06/16/09 Comment


Merck Short Base Rising

Merck & Co. Inc (MRK) the global research-driven pharmaceutical company has seen its short base (as measured by Percent Shares Outstanding on Loan) increase by 57% over the past month to 5.33%.

Pharmaceutical giants Johnson & Johnson (JNJ) and Pfizer Inc. (PFE) have lower short bases of 0.73% and 1.41% respectively. On the other hand two of the more popular shorts are Mylan Inc. (MYL) with a short base of 25.40% and Valeant Pharmaceuticals Inc. (VRX) with 13.85%.
By  trackseekingalpha   (-14.41%  risk: aggressive)  06/10/09 Comment


Are Marijuana Stocks Getting High?
Tradinggoddess
 5 %
Last Thursday, January 22, CNBC presented a program called Marijuana Inc., which went into depth about the big business of marijuana. But besides the illegal uses of marijuana, there are many medical uses. For example, the Journal of Neuroscience reported that the active ingredient in marijuana can be used in the treatment of Alzheimer's disease. Researchers found that cannabinoids can help prevent mental deterioration through the reductions of Alzheimer's related inflammation.

Even members of the government are starting to change their tune on the drug. Bob Barr, a former Republican congres...
By  Trading Goddess   (-46.13%  risk: aggressive)  01/27/09 Comment


Notable Mergers and Acquisitions of the Day 12/10: VRX, YHOO, GNW
<><>Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has signed a definitive agreement to acquire Dow Pharmaceutical Sciences, Inc. for $285 million.Current annualized revenues are approximately $45 million, of which approximately $20 million represents royalty payments from products already out-licensed by Dow. Approximately $8 million in cash will be retained from current Dow accounts, making the net amount paid $277 million. Valeant will make the first payment of $250 million upon closing ($242 million net of cash). In the six month period following closing, Valeant ...
By  Street Insider   (+8.53%  risk: moderate)  12/10/08 Comment


ETF Investing: We Get Sick In Recessions! XPH and IHI Healthcare Stocks

Filed under: Pfizer (PFE), Getting started, Johnson and Johnson (JNJ), Boston Scientific (BSX), Bristol-Myers Squibb (BMY), Merck and Co (MRK), Watson Pharmaceuticals (WPI), ETF Investing

It's one of those unfortunate facts of life, everyone is going to get sick at some time in their lives. It could be something as simple as the common cold or a complex series of symptoms that takes years to diagnose. The upside of all of this is that the medical business is a relatively safe bet when it comes to investments. If you see the benefit of this and want to put some money into a health care relate...
By  Mitch Tuchman   (+15.60%  risk: conservative)  11/20/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.25% 368
2 Gerald Greene 18.14 +70.90% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 60
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
T AT&T Inc
SBUX Starbucks Corp
DRYS DryShips Inc.
GS Goldman Sachs Group Inc The
BIDU Baiducom Inc ADS
AMZN Amazoncom Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on VRX

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Valeant Pharmaceuticals International - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch